Author(s):
G. Sandhya Vani, Ch. Kiranmai, B. Hema Latha, K. Padmalatha
Email(s):
balahemalatha25@gmail.com
DOI:
10.52711/2231-5713.2023.00014
Address:
G. Sandhya Vani1, Ch. Kiranmai1, B. Hema Latha1, K. Padmalatha2
1Department of Pharmaceutics, Vijaya Institute of Pharmaceutical Sciences for women, Vijayawada.
2Department of Pharmacology, Vijaya Institute of Pharmaceutical Sciences for women, Vijayawada.
*Corresponding Author
Published In:
Volume - 13,
Issue - 1,
Year - 2023
ABSTRACT:
Conventional drug delivery systems have slight control over their drug release and nearly uncontrollable over the effective concentration at the target site. This type of dosing pattern might effect on constantly changing, unpredictable plasma concentrations. Drugs can be delivered in a controlled design over a prolonged period of time by the controlled or modified release drug delivery systems. For most of the drugs, oral route is the most tolerable route of administration. Certain molecules may have low oral bioavailability because of solubility or permeability limitations. Evolution of an extended-release dosage form also need sensible absorption throughout the gastro-intestinal tract (GIT). Among the existing techniques to improve the bioavailability of these drugs fabrication of osmotic drug delivery system is the most suitable one. Osmotic drug delivery systems release the drug with the zero-order kinetics at a constant rate. This review brings out advantages, disadvantages, principles, basic components and classification of osmotic drug delivery systems.
Cite this article:
G. Sandhya Vani, Ch. Kiranmai, B. Hema Latha, K. Padmalatha. A Review on Osmotic Drug Delivery System. Asian Journal of Pharmacy and Technology. 2023; 13(1):70-6. doi: 10.52711/2231-5713.2023.00014
Cite(Electronic):
G. Sandhya Vani, Ch. Kiranmai, B. Hema Latha, K. Padmalatha. A Review on Osmotic Drug Delivery System. Asian Journal of Pharmacy and Technology. 2023; 13(1):70-6. doi: 10.52711/2231-5713.2023.00014 Available on: https://ajptonline.com/AbstractView.aspx?PID=2023-13-1-14
REFERENCES:
1. C. M. Dhage, D.M. Shinkar1, V. T Pathan, A. G. Jadhav. A Review on Osmotic Drug Delivery System. International Journal of Pharmaceutical Sciences Review and Research 2020; 62 (1): 160 - 167.
2. Lachman L, Lieberman AH, Kaning LJ. The theory and practice of industrial pharmacy.4th ed., CBS publisher 2015, 620 - 875.
3. Bansode AS, Sarvanan k. Reviews on novel osmotic drug delivery system. Journal of Drug Delivery Therapeutics 2010; 8(5): 87 - 93.
4. Bhagat B, Hapse S, Darkundes. Osmotic Drug Delivery System: An Overview. International Journal of Pharmacy and Pharmaceutical Research 2014; 2(1): 52 - 59.
5. Ghosh T, Ghosh A. Drug delivery through osmotic system an overview. Journal of applied pharmaceutical science 2011; 38 - 49.
6. Gupta P.B, Thakur N, Jain N. P. Osmotically Controlled Drug Delivery System with Associated Drugs. J Pharm Pharmaceutics Sci 2010; 13(3): 571 - 580.
7. Gadwal, P., Rudrawal, P., Ahamad, D, Ahmed A. A review on osmotically regulated devices. International Journal of Pharmacy & Life Sciences 2010; 1(6): 302 - 312.
8. Jensen, J.L., Appel, L.E., Clair, J.H., Zentner, G.M. Variables that affect the mechanism of drug release from osmotic pumps coated with acrylate/methacrylate copolymer latexes. Journal of Pharmaceutical Sciences 1995; 84 (5): 530 - 533.
9. Gohel, M. Parikh, R. K, Shah, N. Y. Osmotic Drug Delivery: An Update. Pharmainfo.net 2009; 7(2): 47 - 50.
10. Ajay, B., Prasada, R., Vijaya, R.J. Controlled-Porosity Osmotic Pump Tablets - An Overview. JPRHC 2010; 2 (1): 114 - 126.
11. Khavare, N.B., Fatima, S. D., Najundaswamy, N.G. A Review on Key Parameters and Components in Designing of Osmotic Controlled Oral Drug Delivery Systems. Indian Journal of Novel Drug delivery 2010; 2(4): 122 - 131.
12. Pandey, S., Viral, D., Formulation and Evaluation of Osmotic Pumps: An Overview. Der Pharmacia Lettre 2010; 2 (1): 189 - 195.
13. B. Lindstedt, G. Ragnarsson, and J. Hjartstam. Osmotic pumping as a release mechanis : 30 years of development and clinical use. European Journal of Pharmaceutics and Biopharmaceutics, 2009; 73: 311 - 323.
14. P. S. I. Wong, B. Barclay, J. C. Deters, and F. Theeuwes. “Osmotic device with dual thermodynamic activity,” US Patent 4612008, 1986.
15. C. Bindschaedler, R. Gurny, and E. Doelker. Mechanically strong films produced from cellulose acetate latexes. Journal of Pharmacy and Pharmacology 1987; 39(5): 335 - 338.
16. D. Ouyang, S. Nie, W. Li, H. Guo, H. Liu, and W. Pan. Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets. Journal of Pharmacy and Pharmacology 2005; 57(7): 817 - 820.
17. Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB. Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release 2000; 68: 145 - 156.
18. Zentner, G.M., Rork, G.S., and Himmelstein, K.J. Controlled porosity osmotic pump, U.S. Patent, 1990; 4, 968, 507.
19. Cortese, R., Theeuwes, F. Simultaneous delivery of two drugs from unit delivery device, US Patent, 1982; 4, 327, 725.
20. Swanson, D. R., Barclay, B. L., Wong, P. S. L. and Theeuwes, F. Nifedipine gastrointestinal therapeutic system. Ameri. J. Med., 1987; 83(6B): 3 - 9.
21. Vyas, S.P. and Khar R.K., Controlled drug delivery. Concepts and Advances, 1st Edn., Vallabh Prakashan, New Delhi, 2002; 477 - 502.
22. Thombre, A. G., Cardinal, J. R., De Noto, A. R., and Gibbes, D. C. Asymmetric membrane capsules for osmotic drug delivery II: In vitro and in vivo drug release performance. J. Contr. Release 1999; 57: 65 - 73.
23. Lin, Y. and Ho, H., Investigations on the drug releasing mechanism from an asymmetric membrane coated capsule with an in situ formed delivery orifice. J. Contr. Release 2003; 89: 57 - 69.
24. Baker, R.W.; Materials Used in Controlled Release Devices, In Controlled Release of Biologically Active Agents; John Wiley and sons, New York, 1987; 172.
25. Theeuwes, F., Wong, P.S.L., Burkoth, T.L. and Fox, D.A., Osmotic systems for colon-targeted drug delivery, In: Bieck, P.R., (Eds)., Colonic drug Absorption and Metabolism, Marcel Dekker, Inc. New York, 1993; 137 - 158.
26. Liu, L., Ku, J., Khang, G., Lee, B., Rhee, J.M. and Lee, H.B., Nifedipine controlled delivery by sandwiched osmotic system. J. Contr. Release 2000; 68: 145 - 156.
27. Schultz, P. and Kleinebudde, P. A new multiparticulate delayed release system: Part 1: Dissolution properties and release mechanism. J. Contr. Release 1997; 47: 181 - 189.
28. Jayendrakumar Patel, Shwetaben Patel. Major Obstacles in Technology Transfer of Nanomedicine from Conception to Commercialization. International Journal of Pharmaceutical Research and Applications 2020; 5 (2): 333 - 342.